Amalgamated Bank

SEC CIK: 0000919192
Latest filing: Jul 23, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 18,682
Value: $11.6M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of REGN by Amalgamated Bank, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	18,682	$11.6M	0.1%	−55−0.3%	Reduced	Holders
Q1 2026	18,737	$14.5M	0.1%	−523−2.7%	Reduced	Holders
Q4 2025	19,260	$14.9M	0.1%	−180−0.9%	Reduced	Holders
Q3 2025	19,440	$10.9M	0.1%	−623−3.1%	Reduced	Holders
Q2 2025	20,063	$10.5M	0.1%	−557−2.7%	Reduced	Holders
Q1 2025	20,620	$13.1M	0.1%	+247+1.2%	Added	Holders
Q4 2024	20,373	$14.5M	0.1%	−2,447−10.7%	Reduced	Holders
Q3 2024	22,820	$24.0M	0.2%	+1,382+6.4%	Added	Holders
Q2 2024	21,438	$22.5M	0.2%	−296−1.4%	Reduced	Holders
Q1 2024	21,734	$20.9M	0.2%	−4,122−15.9%	Reduced	Holders
Q4 2023	25,856	$22.7M	0.2%	−1,191−4.4%	Reduced	Holders
Q3 2023	27,047	$22.3M	0.2%	−639−2.3%	Reduced	Holders
Q2 2023	27,686	$19.9M	0.2%	−3,012−9.8%	Reduced	Holders
Q1 2023	30,698	$25.2M	0.2%	+2,867+10.3%	Added	Holders
Q4 2022	27,831	$20.1M	0.2%	−1,962−6.6%	Reduced	Holders
Q3 2022	29,793	$20.5M	0.2%	+1,604+5.7%	Added	Holders
Q2 2022	28,189	$16.7M	0.2%	+354+1.3%	Added	Holders
Q1 2022	27,835	$19.4M	0.2%	−1,360−4.7%	Reduced	Holders
Q4 2021	29,195	$18.4M	0.1%	+1,753+6.4%	Added	Holders
Q3 2021	27,442	$16.6M	0.1%	−1,019−3.6%	Reduced	Holders
Q2 2021	28,461	$15.9M	0.1%	+22,413+370.6%	Added	Holders
Q1 2021	6,048	$2.86M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.